References
- Beers SL, Abramo TJ. Otitis externa review. Pediatr Emerg Care 2004;20:250-6
- Rosenfeld RM, Brown L, Cannon CR, et al. American Academy of Otolaryngology – Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg 2006;134 (4 Suppl):S4-23
- Roland P, Stroman D. Microbiology of acute otitis externa. Laryngoscope 2002;112:1166-77
- Cortisporin [package insert]. Bristol, TN: Monarch Pharmaceuticals, 2003
- Ciprodex [package insert]. Fort Worth, TX: Alcon Laboratories, Inc., 2004
- Cipro HC [package insert]. Barcelona, Spain: Alcon Cusi, S.A.; 2006
- Floxin [package insert]. Montvale, NJ: Daiichi Pharmaceuticals; 2005
- Cantrell HF, Lombardy EE, Duncanson FP, et al. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials. South Med J 2004;97:465-71
- Sande MA, Mandell GL. Aminoglycosides. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds, Goodman and Gilman's. The Pharmacological Basis of Therapeutics, 8th edn. Oxford: Pergamon Press, 1990: 1112
- Roland PS, Pien FD, Schultz CC, et al. Ciprodex Otic AOE Study Group. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Curr Med Res Opin 2004;20:1175-83
- Rahman A, Rizwan S, Waycaster C, et al. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children. Clin Ther 2007;29:1950-6
- Ciprodex (Ciprofloxacin & Dexamethasone) Sterile Otic Solution. Application No.: 021537. FDA Medical Review and Microbiology Review accessed November 4, 2008. Available at: http://www.fda.gov/cder/foi/nda/2003/021537_Ciprodex.htm
- Weber PC, Roland PS, Hannley M, et al. The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg 2004;130:S89-94
- Roland PS, Belcher BP, Bettis R, et al. Cipro HC Study Group. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa. Am J Otolaryngol 2008;29:255-61
- Barlow DW, Duckert LG, Kreig CS, et al. Ototoxicity of topical otomicrobial agents. Acta Otolaryngol 1995;115:231-5
- Wright CG, Meyerhoff WL. Ototoxicity of otic drops applied to the middle ear in the chinchilla. Am J Otolaryngol 1984;5:166-76
- Brummett RE, Harris RF, Lindgren JA. Detection of ototoxicity from drugs applied topically to the middle ear space. Laryngoscope 1976;86:1177-87
- Claes J, Govaerts PJ, van de Heyning PH, et al. Lack of ciprofloxacin ototoxicity after repeated ototopical application. Antimicrob Agents Chemother 1991;35:1014-16
- Handzel O, Halperin D. Necrotizing (malignant) external otitis. Am Fam Physician 2003;68:309-12